This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. With quarterly earnings underway, BioPharma Dive is providing a snapshot of some companies’ results and how they’re being received by investors. Today, we’re offering insight into the latest numbers from Bristol Myers Squibb, Biogen and Regeneron. Bristol Myers’ legacy lift Bristol Myers Squibb delivered an earnings report on Thursday that analysts describe ...